top of page


Bridging Consulting’s Insights on FDA’s Final Guidance on PCCPs Featured on Leading Platforms
Yu Zhao's article, "Decoding FDA's Final PCCP Guidance," analyzes its impact on AI-driven medical devices and combination products.
Yu Zhao
9 dic 20241 Min. de lectura


Data-Driven Trends In Predetermined Change Control Plans
Data-driven trends show increased FDA authorization of PCCPs, enhancing SaMD compliance and postmarket change controls.
Yu Zhao
12 jul 20249 Min. de lectura


Part III: SaMD PCCP Implementation Beyond AIML: Considerations & Challenges
This article provides tips and practical considerations for PCCP implementation.
Yu Zhao
13 oct 20236 Min. de lectura


Part II: Deciphering New US Laws Around Predetermined Change Control Plan
This article deciphers the new U.S. laws around Predetermined Change Control Plans (PCCP).
Yu Zhao
10 oct 202311 Min. de lectura


Part I: Medical Device Postmarket Change Controls and FDA 510(k) Software Modification Guidance
FDA's guidance on postmarket change controls for 510(k) software modifications ensures SaMD changes maintain safety and compliance.
Yu Zhao
4 oct 20235 Min. de lectura


Implementing a PCCP for Class II SaMD Products Beyond AI/ML
This white paper provides a comprehensive analysis of the PCCP,
along with practical insights into implementation priorities and approaches
Yu Zhao
12 sept 20231 Min. de lectura
bottom of page